KHALI

SHARED STORY

Loading story



Get Khali



Open in app

Free on the App Store

#root { display: none !important; } html, body { height: auto !important; } body { overflow: auto !important; margin: 0; background: #07111f; color: #f4f4f5; font: 16px/1.6 system-ui, sans-serif; } article { box-sizing: border-box; max-width: 760px; margin: 0 auto; padding: 48px 24px 72px; } h1 { font-size: clamp(2rem, 7vw, 3.5rem); line-height: 1.05; } h2 { margin-top: 2rem; } a { color: #64b5ff; }

health · 3 outlets · 3 linked reports

Medicare Will Cover Weight-Loss Drugs for $50 a Month for the First Time

2026-07-06

AI-assisted: summaries and questions may be incomplete or incorrect. Verify important details with the linked original reporting.

Summary

Starting July 1, 2026, Medicare covers Wegovy and Zepbound for weight loss at a flat $50 monthly copay through a temporary 'GLP-1 Bridge' program.
It's the first time Medicare has covered medications specifically for obesity, ending a 20-plus-year coverage ban.
The bridge runs through Dec. 31, 2027, ahead of a possible longer-term program in 2028.

The question

Medicare should cover GLP-1 weight-loss drugs for eligible patients.

Original reporting

Open this story in Khali

Get Khali on the App Store